Table 2 Primary and secondary outcomes results of the symptomatic phase of treatments (non-randomised intervention).
Outcome measures | Before treatments | After treatments | Difference | p value |
|---|---|---|---|---|
Mean pain: VAS (SD), cm | 3.4 ± 2.3 [0-8.1] | 2.3 ± 1.9 [0-8.5] | 1.1 | p = 0.0003 |
NDI (SD) | 22.9 ± 9.3 [0-52] | 18.0 ± 9.6 [0-44] | 4.9 | p = 0.0005 |
BQ (SD) | 25.3 ± 11.6 [2-57] | 18.9 ± 10.9 [2-56] | 6.5 | p = 0.0001 |
Range of motion (°) |  |  |  |  |
Rotation (SD) | 115.2 ± 17.6 [65-151] | 121.7 ± 17.4 [73-160] | 6.5 | p = 0.0161 |
Lateral flexion (SD) | 63.9 ± 17.0 [28-104] | 66.3 ± 15.3 [23-110] | 2.4 | p = 0.3423 |
Flexion-extension (SD) | 119.4 ± 19.0 [52-166] | 105.3 ± 20.5 [52-151] | 14.1 | p < 0.0001 |